ZEISS Participates in the US BRAIN Initiative

Improved imaging tools to better understand the brain

(PresseBox) ( Jena / Washington D.C./USA, )
The National Institutes of Health (NIH) announced its first research grants through President Barack Obama's BRAIN Initiative, including three awards to the University of California, Berkeley, totaling nearly $7.5 million over three years. In addition, a $12 million public-private collaboration between ZEISS and UC Berkeley to support the Berkeley Brain Microscopy Innovation Center (BrainMIC) was made public.

The US Brain initiative is focused on advancing tool development in neuroscience including microscopy and advanced imaging technologies. Jim Sharp, President of the ZEISS business group Microscopy in North America, represented ZEISS at the White House BRAIN Initiative Conference on 30th September. New commitments and investments by the federal government, private sector companies, universities and non-profit organizations in response to the President's call to action were announced.

Thanks to the collaboration with ZEISS, the BrainMIC at UC Berkeley will be able to fast-track microscopy development for emerging neurotechnologies and will run an annual course to teach researchers how to use the new technologies. Part of the Helen Wills Neuroscience Institute, the program will generate innovative devices and analytic tools in engineering, computation, chemistry and molecular biology to enable transformative brain science from studies of human cognition to neural circuits in model organisms.

About ZEISS

ZEISS is an international leader in the fields of optics and optoelectronics. The more than 24,000 employees of ZEISS generated revenue of about 4.2 billion euros in fiscal year 2012/13. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. ZEISS has been contributing to technological progress for more than 160 years. ZEISS develops and produces solutions for the semiconductor, automotive and mechanical engineering industries, biomedical research and medical technology, as well as eyeglass lenses, camera and cine lenses, binoculars and planetariums. ZEISS is present in over 40 countries around the globe with more than 40 production facilities, around 50 sales and service locations and over 20 research and development sites. Carl Zeiss AG is fully owned by the Carl-Zeiss-Stiftung (Carl Zeiss Foundation).
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.